연구동향 분석

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation

이주한 허규하 김범석 박용정 이재근 임범진 정현주 김유선 2015년

논문상세정보
인용/피인용
' The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • angiotensin ii type 1 receptor antibodies
  • antibody-mediated rejection
  • bortezomib
  • hlaantibodies
  • kidney transplantation
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,712 0

0.0%

' The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation' 의 참고문헌

  • Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation
    양근석 Journal of Korean Medical Science 29 (5) : 648 ~ 651 [2014]
  • Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation
    양근석 Journal of Korean Medical Science 29 5 648-651 [2014]
  • Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence
    Sellarés J Am J Transplant 12 : 388 ~ 399 [2012]
  • Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence
    Sellarés J Am J Transplant 12 388-399 [2012]
  • Transplant glomerulopathy: subclinical incidence and association with alloantibody
    Gloor JM Am J Transplant 7 : 2124 ~ 2132 [2007]
  • Transplant glomerulopathy: subclinical incidence and association with alloantibody
    Gloor JM Am J Transplant 7 2124-2132 [2007]
  • The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
    Neubert K Nat Med 14 : 748 ~ 755 [2008]
  • The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
    Neubert K Nat Med 14 748-755 [2008]
  • Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report
    Westphal S Transplant Proc 45 : 1213 ~ 1215 [2013]
  • Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report
    Westphal S Transplant Proc 45 1213-1215 [2013]
  • Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)
    Loupy A Am J Transplant 11 : 56 ~ 65 [2011]
  • Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA)
    Loupy A Am J Transplant 11 56-65 [2011]
  • Role of plasma exchange in ABO-incompatible kidney transplantation
    Yoo S Ann Lab Med 32 : 283 ~ 288 [2012]
  • Role of Plasma Exchange in ABO-incompatible Kidney Transplantation
    Soohun Yoo Annals of Laboratory Medicine 32 4 283-288 [2012]
  • Review of bortezomib treatment of antibody-mediated rejection in renal transplantation
    Ejaz NS Antioxid Redox Signal 21 : 2401 ~ 2418 [2014]
  • Review of bortezomib treatment of antibody-mediated rejection in renal transplantation
    Ejaz NS Antioxid Redox Signal 21 2401-2418 [2014]
  • Proteasome inhibitor-based therapy for antibody-mediated rejection
    Walsh RC Kidney Int 81 : 1067 ~ 1074 [2012]
  • Proteasome inhibitor-based therapy for antibody-mediated rejection
    Walsh RC Kidney Int 81 1067-1074 [2012]
  • Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation
    Kim MG Nephrology (Carlton) 18 : 820 ~ 826 [2013]
  • Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation
    Kim MG Nephrology (Carlton) 18 820-826 [2013]
  • Late antibody-mediated rejection in renal allografts:outcome after conventional and novel therapies
    Gupta G Transplantation 97 : 1240 ~ 1246 [2014]
  • Late antibody-mediated rejection in renal allografts:outcome after conventional and novel therapies
    Gupta G Transplantation 97 1240-1246 [2014]
  • Improved survival in multiple myeloma and the impact of novel therapies
    Kumar SK Blood 111 : 2516 ~ 2520 [2008]
  • Improved survival in multiple myeloma and the impact of novel therapies
    Kumar SK Blood 111 2516-2520 [2008]
  • Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment
    Gertz MA Am J Hematol 89 : 1132 ~ 1140 [2014]
  • Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment
    Gertz MA Am J Hematol 89 1132-1140 [2014]
  • Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition
    Walsh RC Transplantation 91 : 1218 ~ 1226 [2011]
  • Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition
    Walsh RC Transplantation 91 1218-1226 [2011]
  • Duong van Huyen JP, Mooney N, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival
    Loupy A N Engl J Med 369 : 1215 ~ 1226 [2013]
  • Duong van Huyen JP, Mooney N, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival
    Loupy A N Engl J Med 369 1215-1226 [2013]
  • Differential effect of bortezomib on HLA class I and class II antibody
    Philogene MC Transplantation 98 : 660 ~ 665 [2014]
  • Differential effect of bortezomib on HLA class I and class II antibody
    Philogene MC Transplantation 98 660-665 [2014]
  • Diagnosis and management of antibody-mediated rejection:current status and novel approaches
    Djamali A Am J Transplant 14 : 255 ~ 271 [2014]
  • Diagnosis and management of antibody-mediated rejection:current status and novel approaches
    Djamali A Am J Transplant 14 255-271 [2014]
  • Banff 2011 Meeting report: new concepts in antibody-mediated rejection
    Mengel M Am J Transplant 12 : 563 ~ 570 [2012]
  • Banff 2011 Meeting report: new concepts in antibody-mediated rejection
    Mengel M Am J Transplant 12 563-570 [2012]